Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLM | Q9NP87 | 1/20 | 0.57 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.57 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.57 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17372982 | 0.92 | POLM (0.51) | POLMPOLKPOLLPOLH | |
| SCHEMBL27709035 | 0.91 | POLM (0.49) | POLMPOLKPOLLPOLH | |
| SCHEMBL15547990 | 0.85 | POLM (0.54) | POLMPOLKPOLLPOLH | |
| SCHEMBL15549156 | 0.85 | POLM (0.54) | POLMPOLKPOLLPOLH | |
| SCHEMBL15548101 | 0.84 | POLM (0.52) | POLMPOLKPOLLPOLH | |
| SCHEMBL8176584 | 0.83 | POLM (0.57) | POLMPOLKPOLLPOLHFAAH | |
| SCHEMBL30666136 | 0.81 | POLM (0.67) | POLMPOLKPOLLPOLHHTR2A | |
| SCHEMBL15558627 | 0.80 | KDM4E (0.55) | POLMPOLKPOLLPOLH | |
| SCHEMBL6535664 | 0.79 | SCN5A (0.44) | — | |
| SCHEMBL14815784 | 0.79 | SCN5A (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115463106-A | Solid oral dosage forms of lipophilic compounds | 索露奥公司 | 2022-12-13 | — | — | CN | disclosed |
| US-11197828-B2 | Solid oral dosage form of lipophilic compounds | Solural Pharma ApS (DK) | 2021-12-14 | — | — | US | disclosed |
| EP-3157508-B1 | SOLID ORAL DOSAGE FORM OF LIPOPHILIC COMPOUNDS | Solural Pharma ApS (DK) | 2020-12-09 | — | — | EP | disclosed |
| US-20170119674-A1 | SOLID ORAL DOSAGE FORM OF LIPOPHILIC COMPOUNDS | Solural Pharma ApS (DK) | 2017-05-04 | — | — | US | disclosed |
| EP-3157508-A2 | SOLID ORAL DOSAGE FORM OF LIPOPHILIC COMPOUNDS | Solural Pharma Aps (DK) | 2017-04-26 | — | — | EP | disclosed |
| WO-2015193380-A2 | SOLID ORAL DOSAGE FORM OF LIPOPHILIC COMPOUNDS | Solural Pharma ApS (DK) | 2015-12-23 | — | — | WO | disclosed |